RSS

Novoheart

AstraZeneca has announced a collaboration with biotechnology company Novoheart to develop the world’s first functional model of a specific type of heart failure. Read more

News

In the latest 'Meet the maker' EPM chats to Bernard Fermini, chief research & development officer at Novoheart. Bernard talks his love of science, the revolutionary potential of stem cells and why he's a stickler for validation data. Read more

News